Imutex to present positive Phase I clinical study results for AGS-v PLUS mosquito vaccine candidate AGS-v PLUS mosquito vaccine candidate shows favourable safety, tolerability, and immunogenicity ...

SEEK Group and hVIVO (LON:HVO) have teamed up to create Imutex, a startup with a Phase IIa-ready universal flu vaccine and plans to advance a Zika virus shot into the clinic. The founding ...

The joint venture investment in a new company Imutex Limited (“Imutex”) strengthens hVIVO’s commercial flu portfolio and expands it into the adjacent therapeutic area of mosquito-borne ...

The therapy is owned by Imutex – a joint venture with PepTcell – in which hVIVO has a 49% shareholding. The vaccine has a novel proposed dual action mechanism of preventing infection in humans while ...

Adidas , known for shoes with three parallel stripes, was sued on Wednesday by Steven Madden over its alleged effort to stop the American shoe company from selling fashion sneakers with two non ...

Problems with seasonal flu shots have been well documented, and now U.K. biotech Imutex believes it has the next big advance for flu vaccine technology. The company this week reported phase 2b ...

The injection, called FLU-v, created by the British company Imutex, has been found to be more effective than other treatments in development in recent UK trials. In a study involving 123 ...

Phase I results for Imutex's mosquito vaccine candidate published in leading peer-reviewed journal hVIVO plc (AIM & Euronext: HVO) (formerly Open Orphan plc), a rapidly growing specialist contract ...

In 2016, hVIVO formed a joint venture with London-based SEEK Group (SEEK) in a new company, Imutex Limited (Imutex), to accelerate the development of SEEK's AGS-v vaccine and broad-spectrum influenza ...

Here is some other vaccine news of note for the week: > A recent study found that healthcare providers are not recommending HPV vaccination to boys as often as to girls. ABC News article ...

The injection, called FLU-v, created by the British company Imutex, has been found to be more effective than other treatments in development in recent UK trials. In a study involving 123 ...